MétaCan
Menu
Back to cohort
Record W2791778570 · doi:10.1093/jcag/gwy009.151

A151 FECAL CALPROTECTIN RETURN RATE IN IBD PATIENTS ON INFLIXIMAB

2018· article· en· W2791778570 on OpenAlexaffabout
Mansour Altuwaijri, Yvette Leung, Scott Whittaker, Brian Bressler, Greg Rosenfeld

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of British Columbia
Fundersnot available
KeywordsMedicineInfliximabCalprotectinInternal medicineFaecal calprotectinUlcerative colitisLogistic regressionInflammatory bowel diseaseMedical recordRetrospective cohort studyGastroenterologyDisease

Abstract

fetched live from OpenAlex

Fecal calprotectin (FC) is a simple, non-invasive test that has been previously considered a reliable marker of inflammatory bowel disease activity (IBD) and closely correlates with endoscopic evidence of mucosal inflammation. Multiple studies have utilized FC to monitor response to therapy, to assess for mucosal healing and to predict flares during remission. However, the utility of FC may be limited by a low completion rate of the test. To evaluate the return rate of FC stool samples in IBD patients and assess factors associated with completion rate. We conducted a retrospective study of all IBD patients at Pacific Gastroenterology Associates, a tertiary ambulatory care clinic in Vancouver, BC, who are receiving infliximab for IBD and received a requisition for FC testing. Patients received a stool collection kit through the patient support program over the period between March 2016 and July 2017. Demographic data and FC results were obtained through a review of the electronic medical record. Multivariable logistic regression was employed to examine what factors (e.g., age, gender, duration of treatment, and disease indication) were associated with a successfully completed FC test. Data was collected from 120 patients with a median age was 32.5 years, 51% were males and 75% had Crohn’s disease. The median duration time on infliximab was 3.5 years. A FC test was successfully completed by 88 patients (73%). A further 12% of patients (14) have been mailed collection kits but have yet to return them. For 9 patients, the allotted number of samples was exceeded and the samples were not processed and the samples were expired for another 9. Both Univariable and multivariate logistic regression analyses showed that a completed FC was significantly associated with older age (p = 0.03). Despite the usefulness of FC for diagnosing and monitoring IBD activity, the test completion rate is lower than anticipated limiting its value as a clinical tool. The present study suggest that older patients are more likely to complete testing. Measures to improve patient compliance with FC testing in the future could improve the utility of this test in clinical practice. None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.016

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.205
Teacher spread0.201 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of GastroenterologySame topicInflammatory Bowel DiseaseFrench-language works237,207